Anovulation Clinical Trial
Official title:
Visceral Fat Area and Other Predictors of Ovarian Response During Clomiphene Citrate Ovulation Induction in Patients With Polycystic Ovary Syndrome
The purpose of this study is to determine whether Visceral fat area and other criteria assessed during initial screening could predict the response to ovulation induction with clomiphene citrate (CC) in patients with polycystic ovary syndrome (PCOS).
The study was carried out on 150 patients with PCOS. Initial CC doses were 50 mg daily for 5 days starting on cycle day 3. In the case of an absent response, doses were increased to 100 and 150 mg daily in subsequent cycles. First ovulation with CC was used as the end point.Statistical methods Distribution of characteristics in patients is presented as the mean ± SD. We used the Mann-Whitney U test for exploratory comparison of initial parameters between responders and nonresponders. The univariate and multivariate relation with response to CC was assessed using logistic regression analysis. Backward stepwise elimination was used for the multivariate logistic analysis of prediction of patients being CRA, and P < 0.10 was used as a cut-off level for elimination of non-significant predictors from the prognostic model. The area under the receiver operating characteristics (ROC) curve (AUC) was used to assess the discriminative ability of the logistic models. SPSS with statistical package version 17 (SPSS Inc., Chicago, IL) and MedCalc Software version 12.4, (Ostend, Belgium) were employed for data analysis. ;
Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01653743 -
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
|
Phase 3 | |
Completed |
NCT00327366 -
Effect of Bright Light on Sex Hormones and Ovulation in Humans
|
N/A | |
Not yet recruiting |
NCT02551367 -
Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )
|
Phase 2 | |
Completed |
NCT01923194 -
Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females
|
Phase 3 | |
Completed |
NCT01008319 -
Traditional Clomiphene Citrate Administration vs. Stair-step Approach
|
Phase 3 | |
Completed |
NCT00239603 -
Efficacy Study of the OV-Watchâ„¢ Personal Fertility Monitor for Women Using Clomiphene Citrate.
|
Phase 4 | |
Recruiting |
NCT02309047 -
The Cycle Disturbances, OLigomenorrhea and Amenorrhea (COLA) Study & Biobank
|
||
Completed |
NCT03252223 -
Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS
|
Phase 4 | |
Completed |
NCT00492882 -
Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome
|
Phase 4 | |
Completed |
NCT02335879 -
Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
|
Phase 3 | |
Completed |
NCT00471523 -
Treatment of Anovulatory Infertility in PCOS Patients
|
Phase 4 | |
Completed |
NCT02703649 -
Administration of Single High Dose Letrozole for Ovulation Induction
|
Phase 4 | |
Completed |
NCT00213148 -
Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction
|
Phase 2 | |
Completed |
NCT03018314 -
Serum Kisspeptin Levels in Infertile Women
|
N/A | |
Completed |
NCT02710981 -
Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium
|
N/A | |
Recruiting |
NCT02186782 -
Concomitant CC and E2 Versus CC Alone in Ovulation Induction
|
Phase 4 | |
Not yet recruiting |
NCT00665171 -
Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome
|
N/A | |
Withdrawn |
NCT03155828 -
Using CPAP to Improve Menstruation in Women With Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
|
||
Withdrawn |
NCT00453219 -
FHA: Characterization of Metabolic Status, Brain Circuitry, and Stress-Reactivity
|
N/A | |
Completed |
NCT00920634 -
Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)
|